MarketCap
Immuron Limited IMRN
€ 0.86
-0.01%
Facebook
X
Telegram
Immuron Limited PEG | IMRN
PEG Jährlich Immuron Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 4.81 K | 16.6 K | 7.69 K | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16.6 K | 4.81 K | 9.7 K |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Sigilon Therapeutics
SGTX
|
-0.0744 | - | - | $ 728 M |  USA |
 |
Rubius Therapeutics
RUBY
|
0.0044 | - | -33.55 % | $ 7.81 M | USA |
 |
Aptinyx
APTX
|
0.00516 | - | -39.0 % | $ 4.57 M | USA |
 |
TRACON Pharmaceuticals
TCON
|
0.0365 | - | -1.38 % | $ 46.8 M | USA |
 |
Edesa Biotech
EDSA
|
-0.0227 | $ 2.56 | -7.58 % | $ 14.5 M | USA |
 |
Greenwich LifeSciences
GLSI
|
-0.393 | $ 17.42 | 8.67 % | $ 236 M | USA |
 |
Mirati Therapeutics
MRTX
|
-0.0905 | - | - | $ 3.3 B | USA |
 |
Revance Therapeutics
RVNC
|
3.68 | - | - | $ 309 M | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
-0.0024 | - | -37.48 % | $ 476 K | USA |
 |
Epizyme
EPZM
|
-0.122 | - | - | $ 249 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-0.00175 | - | -9.72 % | $ 5.89 M | USA |
 |
Forward Pharma A/S
FWP
|
0.452 | - | -0.75 % | $ 18.7 M |  Danmark |
 |
Orchard Therapeutics plc
ORTX
|
-0.226 | - | 1.02 % | $ 90.8 M |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
-0.145 | - | - | $ 154 M | USA |
 |
Oyster Point Pharma
OYST
|
0.0225 | - | - | $ 300 M | USA |
 |
Nabriva Therapeutics plc
NBRV
|
-0.000204 | - | - | $ 4.55 M |  Irlanda |
 |
Intercept Pharmaceuticals
ICPT
|
0.948 | - | - | $ 643 M | USA |
 |
NGM Biopharmaceuticals
NGM
|
0.0249 | - | - | $ 127 M | USA |
 |
Regulus Therapeutics
RGLS
|
-0.0168 | - | - | $ 155 M | USA |
 |
9 Meters Biopharma
NMTR
|
-0.0112 | - | -42.97 % | $ 1.05 M | USA |
 |
Chinook Therapeutics
KDNY
|
-0.0726 | - | - | $ 2.6 B | USA |
 |
Lumos Pharma
LUMO
|
-0.00131 | - | - | $ 35.3 M | USA |
 |
Syros Pharmaceuticals
SYRS
|
-0.00697 | - | -8.44 % | $ 3.4 M | USA |
 |
Gamida Cell Ltd.
GMDA
|
-0.0775 | - | -18.25 % | $ 5.04 M |  Israel |
 |
Citius Pharmaceuticals
CTXR
|
-0.000437 | $ 0.45 | 13.31 % | $ 4.98 M | USA |
 |
Aravive
ARAV
|
-0.015 | - | -13.39 % | $ 1.45 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
0.181 | - | -74.18 % | $ 955 K | USA |
 |
Novo Nordisk A/S
NVO
|
0.189 | $ 39.12 | 0.17 % | $ 174 B | Danmark |
 |
Abeona Therapeutics
ABEO
|
-0.00404 | $ 4.33 | -1.7 % | $ 229 M | USA |
 |
AIM ImmunoTech
AIM
|
-0.000094 | $ 0.16 | 3.97 % | $ 259 K | USA |
 |
Akebia Therapeutics
AKBA
|
1.03 | $ 0.63 | 11.85 % | $ 162 M | USA |
 |
Aldeyra Therapeutics
ALDX
|
1.65 | $ 0.64 | -2.15 % | $ 38.4 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 228.15 | 1.84 % | $ 29.9 B | USA |
 |
Altimmune
ALT
|
0.647 | $ 2.04 | -3.77 % | $ 180 M | USA |
 |
Assembly Biosciences
ASMB
|
-0.453 | $ 19.65 | -0.96 % | $ 220 M | USA |
 |
Ascendis Pharma A/S
ASND
|
4.41 | $ 245.48 | 0.87 % | $ 14.9 B | Danmark |
 |
Beam Therapeutics
BEAM
|
-1.32 | $ 23.79 | -1.08 % | $ 2.35 B | USA |
 |
Benitec Biopharma
BNTC
|
-0.0443 | $ 8.58 | -0.81 % | $ 399 M | USA |
 |
Capricor Therapeutics
CAPR
|
-0.494 | $ 5.72 | -3.54 % | $ 266 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Cerus Corporation
CERS
|
0.951 | $ 2.37 | 1.5 % | $ 452 M | USA |
 |
Curis
CRIS
|
-0.00281 | $ 0.38 | -2.33 % | $ 5 M | USA |
 |
CorMedix
CRMD
|
0 | $ 7.95 | 1.27 % | $ 573 K | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-0.471 | $ 14.37 | 3.53 % | $ 929 M | USA |
 |
NuCana plc
NCNA
|
82.1 | $ 1.03 | 4.54 % | $ 11.6 B | Britain |
 |
BioVie
BIVI
|
-0.000198 | $ 1.33 | 7.26 % | $ 1.96 M | USA |
 |
CEL-SCI Corporation
CVM
|
-0.00238 | $ 1.6 | -1.84 % | $ 12.8 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
0.306 | $ 1.15 | -9.84 % | $ 60.4 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
-0 | $ 60.7 | -0.87 % | $ 7.29 M | USA |